Harrow Health
Price & Volume
Stats
See moreOpen | $48.95 |
Previous Close | $48.85 |
Day Range | $47.63-$49.03 |
52W Range | $20.85-$59.23 |
Market Cap | $1.8B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $227.6M |
Revenue Growth (YoY) | 30.2% |
Gross Profit (12 Mos) | $169.7M |
Diluted EPS | -$0.28 |
News
See moreYahoo Finance • 10 days ago
Harrow Announces Agenda and Speakers for Investor & Analyst Day
Yahoo Finance • 10 days ago
Implied FYX Analyst Target Price: $122
Yahoo Finance • 16 days ago
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
Yahoo Finance • 17 days ago
Harrow launches $250M debt offering
About
CEO | Mr. Mark L. Baum J.D. |
CFO | Mr. Andrew R. Boll C.F.A., C.M.A. |
Address | 1A Burton Hills Boulevard, Nashville, TN, United States, 37215 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 382 |
